Skip to main content

BaseLaunch is top European accelerator

| News

BaseLaunch is top European accelerator


Healthcare Accelerator BaseLaunch, which is operated by the location promotion organization, is among the leading accelerators of its kind in Europe, according to a media report. BaseLaunch is the only Swiss Healthcare Accelerator to feature.


“Sifted”, an online magazine supported by the “Financial Times”, has analyzed the leading Healthcare Accelerators in Europe. It aimed to find out which accelerators provide healthcare startups with the best opportunities for development and to find investment.

The list of the best European accelerators that specialize in healthcare is very short, with “Sifted” naming just eleven institutions. BaseLaunch, which is operated by, is the only Swiss institution to feature. According to the article, BaseLaunch is the rarest type of accelerator – it provides investment and support without asking for equity in return. Instead, big industry funding comes from companies like NovartisRocheRoivant SciencesJohnson & JohnsonPfizer and KPMG.

Basel is already world-famous in life sciences, but BaseLaunch is supporting even more startups making exciting developments. It offers them business development and legal services, as well as fully equipped labs. Furthermore, grants are available up to 250,000 Swiss francs per company by the end of the 15-month programme. BaseLaunch looks for companies innovating in the therapeutics space, medtech and diagnostics.

In Germany, the only country in which “Sifted” names several high-ranking healthcare accelerators, there are three institutions listed. Like Switzerland, the other countries featured – Great Britain, Sweden, the Netherlands, Spain, Italy, Denmark and Hungary – have only one accelerator included in the ranking.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

The power of a persuasive pitch deck

Are you an entrepreneur striving to secure investment for your biotech startup? Start with an effective pitch deck to catch...
Read More

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

How to access the U.S. market with your medical device

In one of our latest Venture Mentoring events by Basel Are Business & Innovation, we invited Nila-Pia Rähle to speak...
Read More

Do you have a question? We'd like to hear from you.